![[Industry Direct] PHI Studio & Agog Are Seeking Immersive Artists for a Four Week Residency Program](https://roadtovrlive-5ea0.kxcdn.com/wp-content/uploads/2025/05/phi-immersive-residency-2-341x220.jpg?#)
J&J Gene Therapy for Rare, Progressive Vision-Loss Disorder Fails Phase 3 Test
Johnson & Johnson’s gene therapy for X-linked retinal pigmentosa did not meet the main vision goal of a pivotal study. J&J secured full rights to the program from gene therapy biotech MeiraGtx in 2023. The post J&J Gene Therapy for Rare, Progressive Vision-Loss Disorder Fails Phase 3 Test appeared first on MedCity News.
Johnson & Johnson’s gene therapy for X-linked retinal pigmentosa did not meet the main vision goal of a pivotal study. J&J secured full rights to the program from gene therapy biotech MeiraGtx in 2023.
The post J&J Gene Therapy for Rare, Progressive Vision-Loss Disorder Fails Phase 3 Test appeared first on MedCity News.
